Among the 3 genes related to malignant transformation of benign liver lesions that we screened, only SOCS2 was expressed in NAFLD, NASH, and HCC, indicating that its persistent low expression plays a key role in the progression of NAFLD/NASH to HCC. This evidence concerns the gene SOCS2 and metabolic dysfunction-associated steatotic liver disease.